Submitted by Anonymous (not verified) on 11 May 2026 - 14:50
Human medicines European public assessment report (EPAR): Amglidia, glibenclamide, Date of authorisation: 24/05/2018, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Amglidia, glibenclamide, Date of authorisation: 24/05/2018, Revision: 9, Status: Authorised